BRIEF published on 09/06/2024 at 13:12, 2 years ago ARKEMA Reports Share and Voting Rights Count Voting Rights Shares Financial Disclosure Regulated Information ARKEMA
BRIEF published on 09/06/2024 at 13:12, 2 years ago ARKEMA annonce le décompte de ses actions et de ses droits de vote Actions Informations Réglementées Droit De Vote Divulgation Financière ARKEMA
PRESS RELEASE published on 09/06/2024 at 13:07, 2 years ago Inside Information / Other news releases Press release regarding the statement on the number of shares and voting rights as per French commercial code and AMF regulations Voting Rights French Commercial Code Shares AMF Regulated Information
PRESS RELEASE published on 09/06/2024 at 13:07, 2 years ago Informations privilégiées / Autres communiqués Déclaration du nombre total de droits de vote et d'actions conformément à la réglementation financière pour le 6 septembre 2024 Autorité Des Marchés Financiers Déclaration Droits De Vote Actions Réglementé
BRIEF published on 09/05/2024 at 19:05, 2 years ago Arkema Successfully Completes €500 Million Bond Issue Debt Management Bond Issue ARKEMA Financing Policy Materials Science
BRIEF published on 09/05/2024 at 19:05, 2 years ago Arkema clôture avec succès une émission obligataire de 500 millions d'euros Gestion De La Dette Emission D'obligations ARKEMA Politique De Financement Science Des Matériaux
PRESS RELEASE published on 09/05/2024 at 19:00, 2 years ago Inside Information / Other news releases Arkema successfully completed a €500 million senior bond issue with 3.50% annual coupon to extend debt maturity, enhancing financing policy Debt Maturity Bond Issue ARKEMA Financing Policy Materials Science
PRESS RELEASE published on 09/05/2024 at 19:00, 2 years ago Informations privilégiées / Autres communiqués Arkema a placé avec succès une émission obligataire de 500 millions d’euros à 3,50% pour refinancer sa dette et prolonger sa maturité. Leader en matériaux durables et spécialisés Émission Obligataire Refinancement Matériaux Durables ARKEMA Maturité
BRIEF published on 09/03/2024 at 14:25, 2 years ago Arkema Discloses Recent Share Buyback Transactions Transactions Share Buyback Regulations Market ARKEMA
BRIEF published on 09/03/2024 at 14:25, 2 years ago Arkema dévoile ses récentes opérations de rachat d'actions Rachat D'actions Transactions Marché ARKEMA Règlements
Published on 09/11/2026 at 04:00, 5 hours 32 minutes ago Torq Announces Debt Settlement and Corporate Update
Published on 09/10/2026 at 22:25, 11 hours 7 minutes ago Pathfinder Ventures Announces Appointment of Mickey Perret as Chief Executive Officer
Published on 09/10/2026 at 15:20, 18 hours 12 minutes ago MicroVision to Preview Next-Generation Lidar-Based Perception Platform at IAA Transportation 2026
Published on 09/10/2026 at 15:00, 18 hours 32 minutes ago All Randomized Pediatric Patients to Continue in the Single-Blind Extension Phase of Jaguar Health's Pivotal Clinical Trial of Crofelemer for Microvillus Inclusion Disease (MVID) with Intestinal Failure (IF)
Published on 09/11/2026 at 09:20, 11 minutes ago Cantourage Expands Portfolio with New Cannabis Active Ingredients for Innovative Compounded Medicines
Published on 09/11/2026 at 09:05, 26 minutes ago ROHM's New High Anti-surge Chip Resistors in "SDR01 Series" Achieve 0.33W Rated Power in 0402 Size
Published on 09/11/2026 at 09:00, 31 minutes ago Homann Holzwerkstoffe publishes its 2026 half-year report
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago Transparantiekennisgeving van Baltisse Groep
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago BIOPHYTIS ANNOUNCES COMPLETION OF €5.3 MILLION CAPITAL INCREASE TO FUND ITS PHASE 2 TRIAL IN OBESITY
Published on 09/11/2026 at 07:00, 2 hours 32 minutes ago BIOPHYTIS ANNONCE LA RÉALISATION D’UNE AUGMENTATION DE CAPITAL DE 5,3 MILLIONS D’EUROS DESTINÉE À FINANCER SON ESSAI DE PHASE 2 DANS L’OBÉSITÉ
Published on 09/10/2026 at 19:30, 14 hours 2 minutes ago Availability of the 2026 Interim Financial Report
